← Back to Search

Treatment for Tobacco Use (FRESH Trial)

N/A
Waitlist Available
Led By Pebbles Fagan, PhD, MPH
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 3, 6,12 months
Awards & highlights

FRESH Trial Summary

This trial aims to reduce the exposure of African American women and children to tobacco smoke in the Arkansas Delta region.

Eligible Conditions
  • Tobacco Use
  • Secondhand Smoke

FRESH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 3, 6,12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 3, 6,12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comprehensive smokefree policy implementation
Secondary outcome measures
Smoking abstinence
Smoking reduction

FRESH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral TreatmentExperimental Treatment1 Intervention
Following baseline, the CHWs will deliver three doses of the intervention to the treatment (intervention) group over a 6-month period with follow-up at 12 months for all WCGs. At 1, 3, and 6 months, WCGs will receive motivational interviewing, educational materials and biofeedback based on the child's saliva sample and WCG's carbon monoxide.
Group II: ControlActive Control1 Intervention
WCGs will receive educational materials in the mail at 1, 3, and 6 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment
2013
Completed Phase 2
~13740

Find a Location

Who is running the clinical trial?

Coalition for a Tobacco Free ArkansasUNKNOWN
1 Previous Clinical Trials
300 Total Patients Enrolled
Tri-County Rural Health NetworkUNKNOWN
University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,153 Total Patients Enrolled

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT03476837 — N/A
Tobacco Use Research Study Groups: Control, Behavioral Treatment
Tobacco Use Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT03476837 — N/A
Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT03476837 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being enrolled in this study?

"The clinical trial in question, which was originally posted on 1/15/2020, is not currently looking for patients. This is according to the data available on clinicaltrials.gov. The last edit to this study was made on 9/15/2022. There are 59 other studies that are actively recruiting patients at this time."

Answered by AI

Who meets the prerequisites to participate in this research?

"This study is looking for 200 people who have a history of tobacco use and meet the following criteria: Must be between 18-50 years old, smoked cigarettes and/or cigars for at least 1 year, African American women caregivers, Aged 18-50, Primary caregivers of at least one child in the home aged 6 months-14 (birth parent, guardian), Primary decision-maker in the AR home, English speaking, Can provide written informed consent, Working phone and home address, Low income as defined by any indicator (e.g., Medicaid; Earned Income Tax Credit; Children's Health Insurance Plan [ARKids];"

Answered by AI

Is this clinical trial only open to people who are over 60 years old?

"This particular study only enrolls individuals between the ages of 18-50. However, there are 15 separate trials for patients that are under 18 and 39 different clinical trials for adults over the age 65."

Answered by AI
~38 spots leftby Apr 2025